Cardiac tamponade as the initial manifestation of pulmonary adenocarcinoma
Background. Neoplastic pericarditis can be presented as acute pericarditis, pericardial effusion, effusive-constrictive pericarditis or cardiac tamponade. For the majority of patients, a clinical manifestation of neoplastic pericarditis is absent or remains unrecognised during their life.
Case report. A 69-year-old non-smoking woman with acute dyspnoea, tachycardia, jugular venous distension, hepatomegaly and right side pleural effusion was presented in the emergency department. The roentgen picture of the chest confirmed pleural effusion and revealed enlarged heart. An emergency echocardiogram established the diagnosis of cardiac tamponade. The patient improved immediately after the therapeutic pericardiocentesis. Cytology of pericardial fluid confirmed malignant glandular cells, consistent with metastatic adenocarcinoma. A computed chest tomography showed a right side pleural effusion and a solitary round lesion in the right lower lobe of the lung. Bronchoscopy with fundoscopic lung biopsy and brushing revealed adenocarcinoma.
Conclusions. Cardiac tamponade as the initial manifestation of malignancy is rare and rare is also malignant pericardial effusion due the adenocarcinoma of the lung in a non-smoking woman. The presented patient had one of the longest survival reported in literature despite a limited life expectancy regardless of the treatment in the patient presented with neoplastic pericarditis.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Mukai K Shinkai T Tomonaga K Shimoto Y. The incidence of secondary tumors of the heart and pericardium: A ten-year study. Jpn J Clin Oncol 1998; 18: 195-201.
Posner MR Cohen GI Skarin AT. Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med 1981; 71: 407-13.
Fraser RS Viloria JB Wang N. Cardiac tamponade as a presentation of extra cardiac malignancy. Cancer 1980; 45: 1697-704.
Fincher E. Case Report: malignant pericardial effusion as the initial manifestation of malignancy. Am J med Sci 1993; 305: 106-10.
Muir KW Rodger JC. Cardiac tamponade as the initial presentation of malignancy: is it as rare as previously supposed? Postcard Med J 1994; 70: 703-7.
Press OW Livingston R. Management of malignant pericardial effusion and tamponade. JAMA 1987; 257: 1088-92.
Chong HH Plotnick GD. Pericardial effusion and tamponade: evaluation imaging modalities and management. Compr Ther 1995; 21: 378-85.
King DT Nieberg RK. The use of cytology to evaluate pericardial effusions. Ann Clin Lab Sci 1979; 9: 18-23.
Wilding G Green HL Longo DL Urba WJ. Tumors of the heart and pericardium. Cancer Treat Rev 1988; 5: 165-81.
Vaitkus PT Herrmann HC LeWinter MM. Treatment of malignant pericardial effusion. JAMA 1994; 272: 59-64.
Einama T Sato K Tsuda H Mochizuki H. Successful treatment of malignant pericardial effusion using weekly paclitaxel in a patient with breast cancer. Int J Clin Oncol 2006; 11: 412-5.
Martinoni A. Treatment of neoplastic pericardial effusions. Recenti Prog Med 2006; 97: 206-10.
Tomkowski WZ Wisniewska J Szturmowicz M Kuca P Burakowski J Kober J et al. Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade. Support Care Cancer 2004; 12: 53-7.